On the outskirts of Nairobi, Ngong Road is lined by fundi’s stalls – many small workshops making rustic furniture with hand tools, few employees, and limited space and scale. Though it appears that aggregate demand for the goods provided by this industry would allow for scale, consolidation and growth, these small enterprises continue operating at small scale with limited capital and producing goods of moderate quality at high labor cost.
This month IGL begins funding a research project by MIT and EPFL researchers on the market impact of patenting. This question is important because the granting of patent rights is a central public policy tool to incentivizce innovation.
The data revolution is transforming our economy and society, from the way we shop to the way we date. But what about Research, Innovation and Growth (RIG) policy?
Imagine you had $10 million to develop a new programme or policy instrument to support innovation, entrepreneurship or business growth. Given carte blanche, what would you spend it on?
Ahead of the Innovation Growth Lab’s annual conference in Barcelona, we asked five innovation and enterprise experts to answer this question.
Every year we spend quite a lot of time thinking about the key challenges that innovation policymakers face. These are some of the questions that we think are important, and that we will be discussing at the IGL2017 Global Conference in Barcelona on 13-14 June:
There is growing public concern about the challenges the economy of the future presents. From automation to rising inequalities, governments are looking for ways to tackle these issues while rekindling growth rates that have been, in many advanced economies, sluggish.
Last December we co-hosted our winter Research Meeting at Harvard Business School, together with Professors Karim Lakhani and Rembrand Koning. Over 50 researchers were welcomed for a day packed with eight presentations of early-stage, ongoing and completed randomised controlled trials (RCTs).
As more and more governments attempt to base their policies on sound evidence, randomised controlled trials - the 'gold standard' in evaluation - are gaining a stronger role in determining which policies work. But are they really the best way to tell us which policies should be used? This blogpost explores how to improve our ability to learn and better design things that work.
Our estimates for the spending on business support across the European Union, based on our research for the UK, indicate that as much as €152 billion were spent in 2014. In this blog, we explore what this means for Europe, and what could be done better.